Home Cart 0 Sign in  
X

[ CAS No. 64068-00-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 64068-00-4
Chemical Structure| 64068-00-4
Chemical Structure| 64068-00-4
Structure of 64068-00-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 64068-00-4 ]

Related Doc. of [ 64068-00-4 ]

Alternatived Products of [ 64068-00-4 ]

Product Details of [ 64068-00-4 ]

CAS No. :64068-00-4 MDL No. :MFCD19203440
Formula : C5H6ClN3 Boiling Point : -
Linear Structure Formula :- InChI Key :HSAHCMOZFNSMLH-UHFFFAOYSA-N
M.W : 143.57 Pubchem ID :12353664
Synonyms :

Calculated chemistry of [ 64068-00-4 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.2
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 36.41
TPSA : 51.8 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.59 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.39
Log Po/w (XLOGP3) : 0.82
Log Po/w (WLOGP) : 1.03
Log Po/w (MLOGP) : 0.74
Log Po/w (SILICOS-IT) : 1.31
Consensus Log Po/w : 1.06

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.74
Solubility : 2.61 mg/ml ; 0.0182 mol/l
Class : Very soluble
Log S (Ali) : -1.49
Solubility : 4.65 mg/ml ; 0.0324 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.27
Solubility : 0.766 mg/ml ; 0.00533 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.96

Safety of [ 64068-00-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 64068-00-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 64068-00-4 ]
  • Downstream synthetic route of [ 64068-00-4 ]

[ 64068-00-4 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 19064-64-3 ]
  • [ 66346-87-0 ]
  • [ 64068-00-4 ]
YieldReaction ConditionsOperation in experiment
43.5% With ammonia In ethanol at 120℃; for 12 h; Heating in a sealed tube [Linholter, S., et a/, Acta Chem. Scand. 15: 1660-1666 (1961 )]. To a solution of 3,6-dichloro-4-methyl-pyridazine (200 mg) in ethanol (3ml) was added liquid ammonia (3 ml). The reaction mixture was heated at 120 0C in a sealed tube for 12 h. After cooling to room temperature, methanol and ammonia were evaporated. The residue was purified by flash chromatography (ethyl acetate) to afford 153 mg of mixture of 7 and 10 (1 :1 ), (87percent), which was used without any further separation.
10% at 120℃; for 18 h; Autoclave A mixture of 3,6-dichloro-4-methylpyridazine (5 g, 30.7 mmol) and concentrated NH40H solution (100 ml) was heated to 120° in a sealed autoclave for 18 hrs at 6 bar. The mixture was cooled to r.t, diluted with water (200 ml) and stirred in an ice bath for 2 hrs. The solid was collected by filtration, washed with water and dried. The filtrate was extracted with CH2Cl2/MeOH (9: 1). The organic was washed with brine, dried over MgSC^, filtered and evaporated. The precipitate from the reaction mixture and the solid isolated by extraction were combined. This crude product was purified by column chromatography using a CH2Cl2/MeOH gradient as eluent, to provide 6-chloro-4-methylpyridazin-3-amine (456 mg, 10percent) and 6-chloro-5-methylpyridazin- 3-amine (350 mg, 8percent>), both as off-white solids. MS: M = 144.1 (M+H)+ (both isomers)
22.4 g at 110℃; for 48 h; Sealed tube In a sealed flask, 3,6-dichloro-4-methylpyridazine (27 g, 161 mmol) was suspended in aqueous ammonia (25percent, 300 mL). The reaction mixture was heated at 110 °C for 48 hours (turned into solution after 1 hour). After cooling to room temperature, the reaction was poured into CH2C12, and the organic phase was separated, dried over Na2SO4, and concentrated under vacuum, to give 22.4 g of 6-chloro-4-methyl-pyridazin-3-amine and 6-chloro-5-methyl-pyridazin-3-amine as a mixture of regioisomers which were used directly in the next step.
22.4 g at 110℃; for 48 h; In a sealed flask, 3,6-dichloro-4-methylpyridazine (27 g, 161 mmol) was suspended in aqueous ammonia (25percent, 300 mL). The reaction mixture was heated at 110 °C for 48 hours (turned into solution after 1 hour). After cooling to room temperature, the reaction was poured into CH2C12, and the organic phase was separated, dried over Na2SO4, and concentrated under vacuum, to give 22.4 g of 6-chloro-4-methyl-pyridazin-3-amine and 6-chloro-5-methyl-pyridazin-3-amine as a mixture of regioisomers which were used directly in the next step.

Reference: [1] Patent: WO2007/33080, 2007, A2, . Location in patent: Page/Page column 26; 37
[2] Patent: WO2014/72261, 2014, A1, . Location in patent: Page/Page column 48
[3] Pharmaceutical Bulletin, 1957, vol. 5, p. 229,233
[4] Australian Journal of Chemistry, 1986, vol. 39, # 11, p. 1803 - 1809
[5] Pharmaceutical Bulletin, 1957, vol. 5, p. 229,233
[6] Acta Chemica Scandinavica (1947-1973), 1961, vol. 15, p. 1660,1665
[7] Patent: US2006/84802, 2006, A1, . Location in patent: Page/Page column 75
[8] Patent: WO2010/60472, 2010, A1, . Location in patent: Page/Page column 15
[9] Patent: US2010/267730, 2010, A1, . Location in patent: Page/Page column 8
[10] Patent: US2007/78136, 2007, A1, . Location in patent: Page/Page column 46
[11] Patent: US2011/312934, 2011, A1, . Location in patent: Page/Page column 17
[12] Patent: US2012/10208, 2012, A1, . Location in patent: Page/Page column 6
[13] Patent: WO2012/69202, 2012, A1, . Location in patent: Page/Page column 54-55
[14] Patent: EP2463289, 2012, A1, . Location in patent: Page/Page column 22
[15] Patent: WO2013/59587, 2013, A1, . Location in patent: Page/Page column 105
[16] Patent: US2013/273037, 2013, A1, . Location in patent: Paragraph 0675-0677
[17] Patent: WO2015/48245, 2015, A1, . Location in patent: Paragraph 00190
[18] Patent: WO2015/173181, 2015, A1, . Location in patent: Page/Page column 33
[19] Patent: WO2016/198908, 2016, A1, . Location in patent: Page/Page column 68
[20] Patent: EP2768509, 2017, B1, . Location in patent: Paragraph 0362; 0363
[21] Patent: WO2017/81111, 2017, A1, . Location in patent: Page/Page column 33
[22] Patent: WO2017/80967, 2017, A1, . Location in patent: Page/Page column 55
[23] Patent: WO2017/192930, 2017, A1, . Location in patent: Paragraph 00254; 00322
[24] Journal of Medicinal Chemistry, 2018, vol. 61, # 15, p. 6501 - 6517
[25] Patent: WO2009/109743, 2009, A1, . Location in patent: Page/Page column 52; 53
  • 2
  • [ 19064-64-3 ]
  • [ 66346-87-0 ]
  • [ 64068-00-4 ]
YieldReaction ConditionsOperation in experiment
43.5% With ammonia In ethanol at 120℃; for 12 h; Heating in a sealed tube [Linholter, S., et a/, Acta Chem. Scand. 15: 1660-1666 (1961 )]. To a solution of 3,6-dichloro-4-methyl-pyridazine (200 mg) in ethanol (3ml) was added liquid ammonia (3 ml). The reaction mixture was heated at 120 0C in a sealed tube for 12 h. After cooling to room temperature, methanol and ammonia were evaporated. The residue was purified by flash chromatography (ethyl acetate) to afford 153 mg of mixture of 7 and 10 (1 :1 ), (87percent), which was used without any further separation.
10% at 120℃; for 18 h; Autoclave A mixture of 3,6-dichloro-4-methylpyridazine (5 g, 30.7 mmol) and concentrated NH40H solution (100 ml) was heated to 120° in a sealed autoclave for 18 hrs at 6 bar. The mixture was cooled to r.t, diluted with water (200 ml) and stirred in an ice bath for 2 hrs. The solid was collected by filtration, washed with water and dried. The filtrate was extracted with CH2Cl2/MeOH (9: 1). The organic was washed with brine, dried over MgSC^, filtered and evaporated. The precipitate from the reaction mixture and the solid isolated by extraction were combined. This crude product was purified by column chromatography using a CH2Cl2/MeOH gradient as eluent, to provide 6-chloro-4-methylpyridazin-3-amine (456 mg, 10percent) and 6-chloro-5-methylpyridazin- 3-amine (350 mg, 8percent>), both as off-white solids. MS: M = 144.1 (M+H)+ (both isomers)
22.4 g at 110℃; for 48 h; Sealed tube In a sealed flask, 3,6-dichloro-4-methylpyridazine (27 g, 161 mmol) was suspended in aqueous ammonia (25percent, 300 mL). The reaction mixture was heated at 110 °C for 48 hours (turned into solution after 1 hour). After cooling to room temperature, the reaction was poured into CH2C12, and the organic phase was separated, dried over Na2SO4, and concentrated under vacuum, to give 22.4 g of 6-chloro-4-methyl-pyridazin-3-amine and 6-chloro-5-methyl-pyridazin-3-amine as a mixture of regioisomers which were used directly in the next step.
22.4 g at 110℃; for 48 h; In a sealed flask, 3,6-dichloro-4-methylpyridazine (27 g, 161 mmol) was suspended in aqueous ammonia (25percent, 300 mL). The reaction mixture was heated at 110 °C for 48 hours (turned into solution after 1 hour). After cooling to room temperature, the reaction was poured into CH2C12, and the organic phase was separated, dried over Na2SO4, and concentrated under vacuum, to give 22.4 g of 6-chloro-4-methyl-pyridazin-3-amine and 6-chloro-5-methyl-pyridazin-3-amine as a mixture of regioisomers which were used directly in the next step.

Reference: [1] Patent: WO2007/33080, 2007, A2, . Location in patent: Page/Page column 26; 37
[2] Patent: WO2014/72261, 2014, A1, . Location in patent: Page/Page column 48
[3] Pharmaceutical Bulletin, 1957, vol. 5, p. 229,233
[4] Australian Journal of Chemistry, 1986, vol. 39, # 11, p. 1803 - 1809
[5] Pharmaceutical Bulletin, 1957, vol. 5, p. 229,233
[6] Acta Chemica Scandinavica (1947-1973), 1961, vol. 15, p. 1660,1665
[7] Patent: US2006/84802, 2006, A1, . Location in patent: Page/Page column 75
[8] Patent: WO2010/60472, 2010, A1, . Location in patent: Page/Page column 15
[9] Patent: US2010/267730, 2010, A1, . Location in patent: Page/Page column 8
[10] Patent: US2007/78136, 2007, A1, . Location in patent: Page/Page column 46
[11] Patent: US2011/312934, 2011, A1, . Location in patent: Page/Page column 17
[12] Patent: US2012/10208, 2012, A1, . Location in patent: Page/Page column 6
[13] Patent: WO2012/69202, 2012, A1, . Location in patent: Page/Page column 54-55
[14] Patent: EP2463289, 2012, A1, . Location in patent: Page/Page column 22
[15] Patent: WO2013/59587, 2013, A1, . Location in patent: Page/Page column 105
[16] Patent: US2013/273037, 2013, A1, . Location in patent: Paragraph 0675-0677
[17] Patent: WO2015/48245, 2015, A1, . Location in patent: Paragraph 00190
[18] Patent: WO2015/173181, 2015, A1, . Location in patent: Page/Page column 33
[19] Patent: WO2016/198908, 2016, A1, . Location in patent: Page/Page column 68
[20] Patent: EP2768509, 2017, B1, . Location in patent: Paragraph 0362; 0363
[21] Patent: WO2017/81111, 2017, A1, . Location in patent: Page/Page column 33
[22] Patent: WO2017/80967, 2017, A1, . Location in patent: Page/Page column 55
[23] Patent: WO2017/192930, 2017, A1, . Location in patent: Paragraph 00254; 00322
[24] Journal of Medicinal Chemistry, 2018, vol. 61, # 15, p. 6501 - 6517
[25] Patent: WO2009/109743, 2009, A1, . Location in patent: Page/Page column 52; 53
  • 3
  • [ 446273-59-2 ]
  • [ 544-97-8 ]
  • [ 64068-00-4 ]
YieldReaction ConditionsOperation in experiment
80% With tetrakis(triphenylphosphine) palladium(0) In N,N-dimethyl-formamide at 20℃; 6-Chloro-4-methylpyridazin-3-amineA 100 mL flask was charged with 4-bromo-6-chloropyridazin-3-amine (1 g, 4.80 mmol), dimethylzinc (9.59 mL, 9.59 mmol), Pd(PPh3)4 (0.277 g, 0.240 mmol) and DMF (10 mL). The reaction mixture was stirred at RT. Then the reaction mixture was quenched with MeOH and concentrated. The crude product was loaded onto a 10 g SCX SPE, and 3 volumes of MeOH followed by 3 volumes of 2N ammonia in MeOH were added. The fractions were combined and concentrated to afford 6-chloro-4-methylpyridazin-3-amine (693 mg, 80percent yield).
Reference: [1] Patent: WO2013/12500, 2013, A1, . Location in patent: Page/Page column 90-91
  • 4
  • [ 19064-64-3 ]
  • [ 64068-00-4 ]
Reference: [1] Patent: US2006/116368, 2006, A1, . Location in patent: Page/Page column 32
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 64068-00-4 ]

Chlorides

Chemical Structure| 66346-87-0

[ 66346-87-0 ]

6-Chloro-5-methylpyridazin-3-amine

Similarity: 0.87

Chemical Structure| 17284-97-8

[ 17284-97-8 ]

3-Chloro-6-hydrazinylpyridazine

Similarity: 0.74

Chemical Structure| 14959-32-1

[ 14959-32-1 ]

3-Chloro-6-(methylamino)pyridazine

Similarity: 0.74

Chemical Structure| 7145-60-0

[ 7145-60-0 ]

6-Chloro-N,N-dimethylpyridazin-3-amine

Similarity: 0.70

Chemical Structure| 34584-69-5

[ 34584-69-5 ]

3,6-Dichloro-4,5-dimethylpyridazine

Similarity: 0.68

Amines

Chemical Structure| 66346-87-0

[ 66346-87-0 ]

6-Chloro-5-methylpyridazin-3-amine

Similarity: 0.87

Chemical Structure| 17284-97-8

[ 17284-97-8 ]

3-Chloro-6-hydrazinylpyridazine

Similarity: 0.74

Chemical Structure| 14959-32-1

[ 14959-32-1 ]

3-Chloro-6-(methylamino)pyridazine

Similarity: 0.74

Chemical Structure| 7145-60-0

[ 7145-60-0 ]

6-Chloro-N,N-dimethylpyridazin-3-amine

Similarity: 0.70

Chemical Structure| 932-50-3

[ 932-50-3 ]

6-Chloropyridazine-3,4-diamine

Similarity: 0.67

Related Parent Nucleus of
[ 64068-00-4 ]

Pyridazines

Chemical Structure| 66346-87-0

[ 66346-87-0 ]

6-Chloro-5-methylpyridazin-3-amine

Similarity: 0.87

Chemical Structure| 17284-97-8

[ 17284-97-8 ]

3-Chloro-6-hydrazinylpyridazine

Similarity: 0.74

Chemical Structure| 14959-32-1

[ 14959-32-1 ]

3-Chloro-6-(methylamino)pyridazine

Similarity: 0.74

Chemical Structure| 7145-60-0

[ 7145-60-0 ]

6-Chloro-N,N-dimethylpyridazin-3-amine

Similarity: 0.70

Chemical Structure| 34584-69-5

[ 34584-69-5 ]

3,6-Dichloro-4,5-dimethylpyridazine

Similarity: 0.68